Changzhou Jiubang Pharmaceutical

Changzhou Jiubang Pharmaceutical is a specialized pharmaceutical company headquartered in Changzhou, China, focusing on the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and high-end intermediates. The company has established a strong presence in the antiviral sector, particularly in the synthesis of intermediates for treatments targeting Hepatitis B (HBV) and Hepatitis C (HCV), such as Entecavir, Tenofovir, and Sofosbuvir. In addition to its antiviral portfolio, Jiubang provides chemical products for cardiovascular and oncology applications. The firm operates a manufacturing facility in the Binjiang Economic Development Zone that adheres to international quality standards, including ISO certifications. As a contract development and manufacturing organization (CDMO), it offers custom synthesis and process optimization services to the global life sciences industry.